VetSheet

Epsiprantel

Pyrazino-benzazepine

Antiparasitic - CestocidePODogsCats

Also known as: Cestex ยท BRL-38705

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

5.5 mg/kg (2.5 mg/lb)POยท onceยท Single dose
โ€” ๐Ÿ•

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Dosing by species

๐ŸŒŽ NA โ€” North America๐ŸŒ EU โ€” Europe

Dogs

IndicationDoseRouteFrequencyDurationRegion
Cestode infection (Dipylidium caninum, Taenia pisiformis)5.5 mg/kg (2.5 mg/lb)POonceSingle dose๐ŸŒŽ NA
  • Cestode infection (Dipylidium caninum, Taenia pisiformis): Round up to the next larger tablet size

Cats

IndicationDoseRouteFrequencyDurationRegion
Cestode infection (Dipylidium caninum, Taenia taeniaeformis)2.75 mg/kgPOonceSingle dose๐ŸŒŽ NA
  • Cestode infection (Dipylidium caninum, Taenia taeniaeformis): Cats up to 10 lb should receive one 12.5 mg tablet; cats 11-20 lb should receive one 25 mg tablet

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Epsiprantel is an oral cestocidal antiparasitic agent used primarily for the treatment of tapeworm infections in dogs and cats.

  • Indications: Highly effective for the removal of Dipylidium caninum and Taenia pisiformis in dogs, and Dipylidium caninum and Taenia taeniaeformis in cats.
  • Clinical Pearl: Unlike praziquantel, epsiprantel is very poorly absorbed from the gastrointestinal tract. This lack of systemic absorption contributes to its exceptionally wide safety margin and minimal risk of systemic adverse effects.

Mechanism of action

While the exact mechanism of action against cestodes is not fully elucidated, epsiprantel acts directly on the tapeworm:

  • Calcium Dysregulation โ†’ Induces severe tetany (muscle spasms) in the parasite.
  • Attachment Disruption โ†’ Causes the tapeworm to lose its grip on the host's intestinal mucosa.
  • Integument Alteration โ†’ Damages the worm's outer protective layer, rendering it highly vulnerable to digestion by the host animal's gastrointestinal enzymes.

Safety & warnings

Contraindications

  • Puppies less than 7 weeks of age
  • Kittens less than 7 weeks of age

Adverse effects

  • Vomiting (rare)
  • Diarrhea (rare)

Precautions

Age Restriction: The manufacturer states not to use in puppies or kittens less than 7 weeks of age.

Safety for use in pregnant or breeding animals has not been definitively determined, though teratogenic effects are highly unlikely due to the drug's extremely poor systemic absorption.

Drug interactions

Prokinetic agents

Theoretically may reduce the drug's efficacy by decreasing gastrointestinal transit time

Fast-acting laxatives

Theoretically may reduce the drug's efficacy

Monitoring

  • Clinical efficacy (resolution of tapeworm infection)

Pharmacokinetics

Absorption

Absorbed very poorly after oral administration.

Distribution

Remains primarily within the gastrointestinal tract.

Metabolism

No metabolites have thus far been detected.

Elimination

The bulk of the drug is eliminated unchanged in the feces. Less than 0.1% of the drug is recovered in the urine after dosing.

Overdose

Acute toxicity resulting from an inadvertent overdose is highly unlikely due to poor systemic absorption.

  • Cats: Doses as high as 36X the recommended dose resulted in vomiting in some of the kittens tested.
  • Dogs: Single doses of 36X those recommended in dogs caused no adverse effects.

Available products

Formulations

  • Oral tablets

Veterinary

  • Epsiprantel Oral Tablets (Film-coated): 12.5 mg, 25 mg, 50 mg & 100 mg; Cestexยฎ (Pfizer)

Regulatory status

No regulatory data for: ๐Ÿ‡บ๐Ÿ‡ธ US ยท ๐Ÿ‡ช๐Ÿ‡บ EU ยท ๐Ÿ‡ฌ๐Ÿ‡ง UK ยท ๐Ÿ‡ญ๐Ÿ‡ฐ HK ยท ๐Ÿ‡น๐Ÿ‡ผ TW ยท ๐Ÿ‡ฏ๐Ÿ‡ต JP ยท ๐Ÿ‡ฐ๐Ÿ‡ท KR ยท ๐Ÿ‡ฆ๐Ÿ‡บ AU

Storage & stability

Tablets should be stored at room temperature.

Client information

  • No Fasting Required: Fasting is not required nor is it recommended before dosing. You can give this medication with or without food.
  • Invisible Results: Because the medication damages the tapeworm and causes it to be partially or completely digested by your pet's body, you likely will not see dead worms or worm fragments in the stool after treatment.
  • Prevent Reinfection: A single dose is usually effective. However, since the most common tapeworm (Dipylidium caninum) is transmitted by swallowing infected fleas, strict flea control is essential to prevent your pet from getting tapeworms again.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturerโ€™s current label.